全文获取类型
收费全文 | 77522篇 |
免费 | 4811篇 |
国内免费 | 2038篇 |
专业分类
耳鼻咽喉 | 441篇 |
儿科学 | 1155篇 |
妇产科学 | 751篇 |
基础医学 | 8578篇 |
口腔科学 | 1158篇 |
临床医学 | 7353篇 |
内科学 | 11512篇 |
皮肤病学 | 415篇 |
神经病学 | 9189篇 |
特种医学 | 2333篇 |
外国民族医学 | 2篇 |
外科学 | 5931篇 |
综合类 | 11428篇 |
现状与发展 | 6篇 |
预防医学 | 10626篇 |
眼科学 | 711篇 |
药学 | 8103篇 |
110篇 | |
中国医学 | 2433篇 |
肿瘤学 | 2136篇 |
出版年
2024年 | 136篇 |
2023年 | 1184篇 |
2022年 | 1860篇 |
2021年 | 3286篇 |
2020年 | 2884篇 |
2019年 | 2561篇 |
2018年 | 2590篇 |
2017年 | 2326篇 |
2016年 | 2422篇 |
2015年 | 2434篇 |
2014年 | 5179篇 |
2013年 | 5454篇 |
2012年 | 4584篇 |
2011年 | 5074篇 |
2010年 | 3923篇 |
2009年 | 3813篇 |
2008年 | 3966篇 |
2007年 | 3638篇 |
2006年 | 3250篇 |
2005年 | 2797篇 |
2004年 | 2301篇 |
2003年 | 2012篇 |
2002年 | 1597篇 |
2001年 | 1381篇 |
2000年 | 1150篇 |
1999年 | 972篇 |
1998年 | 935篇 |
1997年 | 922篇 |
1996年 | 772篇 |
1995年 | 731篇 |
1994年 | 716篇 |
1993年 | 624篇 |
1992年 | 583篇 |
1991年 | 560篇 |
1990年 | 467篇 |
1989年 | 424篇 |
1988年 | 434篇 |
1987年 | 400篇 |
1986年 | 371篇 |
1985年 | 541篇 |
1984年 | 521篇 |
1983年 | 362篇 |
1982年 | 360篇 |
1981年 | 366篇 |
1980年 | 309篇 |
1979年 | 243篇 |
1978年 | 224篇 |
1977年 | 195篇 |
1976年 | 165篇 |
1975年 | 111篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Marieke C Wichers Gunter Kenis Carsten Leue Ger Koek Geert Robaeys Michael Maes 《Neuropsychopharmacology》2006,60(1):77-79
BACKGROUND: Major depression has been associated cross-sectionally with increased cell-mediated immune activation but causality has been difficult to establish. This study prospectively investigated the hypothesis that baseline level of immune activation predicts the development of depression during interferon-alpha (IFN-alpha) treatment. METHODS: Sixteen hepatitis C patients without psychiatric disorder underwent IFN-alpha treatment. Proinflammatory and anti-inflammatory cytokines were determined before starting treatment. Presence of a major depressive disorder (MDD) was assessed at baseline and several times during treatment. RESULTS: Baseline soluble interleukin-2 receptor (sIL-2r), interleukin-6 (IL-6), and interleukin-10 (IL-10) concentrations were significantly increased in the five subjects that developed MDD during treatment compared with those that did not, with standardized effect sizes of 1.08, 1.16, and 1.25, respectively, controlling for marijuana use, cigarette smoking, and baseline level of depressive symptoms. CONCLUSIONS: Results suggest that increased immune activation, rather than an epiphenomenon, is a causal risk factor for the development of MDD. 相似文献
102.
心血管造影在复杂和(或)复合先天性心脏病诊断中的应用 总被引:2,自引:0,他引:2
目的 探讨心血管造影在先天性心脏病(简称先心病)复杂和(或)复合畸形中的应用价值。方法 分析360例复杂和(或)复合畸形造影所见及其与超声心动图等临床检查的联系。结果 本组360例(包括75例肺动脉闭锁合并室间隔缺损、62例右室双出口、60例法乐四联症、52例单心室、42例大动脉错位、15例三尖闭锁、6例冠状动脉异常、5例完整型肺静脉畸形连接、5例完全型心内膜垫缺损、4例共同动脉干、3例室间完整的肺动脉闭锁、7例其他病例和24例外科术后检查)心血管造影和超声对比,纠正后者误、漏诊分别为34、30例及对合并畸形误诊16例。对复杂和(或)复合畸形中体肺侧支血管、冠状动脉畸形和肺动脉段分支及其异常的检测和诊断优于超声心动图,并可测量肺动、静脉压力及体肺侧支血管压力而优于其他影像学检查方法。结论 对于先心病复杂和(或)复合畸形的疑难病例诊断和鉴别诊断,尤其显示体、肺及冠状动脉分支的全貌及相关病变,以及测量肺动脉和心室压力等,心血管造影(含DSA)仍有重要或不可替代的作用。 相似文献
103.
雷米芬太尼对无抽搐电休克治疗心血管反应的影响 总被引:4,自引:1,他引:3
目的研究雷米芬太尼对无抽搐电休克(MECT)治疗心血管反应的影响。方法32例抑郁症患者随机分成对照组与雷米芬太尼组,每组16例。对照组采用丙泊酚1.5mg/kg静脉麻醉;雷米芬太尼组给予等量丙泊酚加1μg/kg雷米芬太尼静脉麻醉。全麻诱导后皆静注琥珀酰胆碱,待肌肉松驰后行MECT治疗。全程监测患者ECG、HR、MAP、SpO2,并观察记录患者癫痫发作时间、自主呼吸恢复时间、苏醒时间。结果MECT治疗后即刻、1、3min两组HR、MAP较麻醉前明显升高(P<0.05或P<0.01),但雷米芬太尼组明显低于对照组(P<0.05);自主呼吸恢复时间雷米芬太尼组略长于对照组(P<0.05),但均在10min以内;癫痫发作时间、苏醒时间、SpO2两组差异无显著意义。结论雷米芬太尼适合应用于MECT治疗麻醉并可明显抑制MECT引起心血管反应。 相似文献
104.
目的为了探索一套适合我国社区卫生服务机构持续健康发展的护理管理模式,以提高社区护理管理效应。通过专家评定法以及全体护理人员讨论的方法,给予每项护理工作以适当的权重,以此建立社区护理工作绩效量化评价体系,并组织实施。实施后,在社区护理工作方面形成了良好的管理导向,建立了有效的激励机制,提高了护理工作质量、效率和效益。因此,可以认为在社区护理实施工作绩效量化评价体系,是值得推广的一项举措。 相似文献
105.
106.
Anne Pavy-Le Traon Richard L Hughson Claire Thalamas Monique Galitsky Nelly Fabre Olivier Rascol Jean-Michel Senard 《Movement disorders》2006,21(12):2122-2126
Patients with multiple system atrophy (MSA) present large changes in blood pressure (BP) due to autonomic disturbances. We analyzed how this change may influence dynamic cerebral autoregulation (DCA). Simultaneous recordings of arterial BP (Finapres) and middle cerebral artery (MCA) blood flow velocity (BFV) (transcranial Doppler) were performed in 10 patients with MSA (61 +/- 12 yr of age) and 12 healthy volunteers (61 +/- 11 yr of age): cerebral BFV response to oscillations in mean BP was studied in the supine position by cross-spectral analysis of mean BP and mean MCA BFV. The DCA was also studied during the decrease in BP the first seconds when standing up from a sitting position by the assessment of the cerebrovascular resistance index (CR; mean BP/mean MCA BFV ratio). The MCA BFV/BP cross-spectral analysis showed a phase for the mid-frequency band (0.07-0.2 Hz) significantly larger in MSA, suggesting more active autoregulation in response to larger changes in BP. Changes in CR reflecting the rate of autoregulation, when standing did not differ between the two groups. These data suggest that dynamic cerebral autoregulation is preserved in MSA. 相似文献
107.
目的探讨缺氧缺血性脑病(hypoxia-ischem ia encephalopathy,H IE)胎儿和H IE新生儿血清中促血小板生成素(Thrombopoietin,TPO)水平与脑损伤的关系,为脑瘫(cerebral palsy,CP)高危儿人群进行早期干预提供监测手段。方法收集23例H IE胎儿和34例H IE新生儿血清以及25例正常胎儿和30例正常新生儿血清,34例H IE新生儿包括11例轻度H IE,8例中度H IE和15例重度H IE。采用双抗体夹心ABC-ELISA法检测H IE胎儿组和轻、中、重H IE新生儿组血清中TPO的水平,并与正常胎儿组和正常新生儿组比较。结果H IE胎儿组和H IE新生儿组TPO分别高于正常胎儿组和正常新生儿组(分别P<0.01,P<0.01),重度H IE组TPO低于轻度H IE组(P<0.05)。结论血清TPO水平与H IE所致脑损伤严重程度有关。脐血TPO检测可为脑瘫高危儿人群进行早期干预提供监测手段。 相似文献
108.
By substituting the saturated vapour phase tension of the pure normal hydrocarbons described by the Clausius-Clapeyron law into the accepted expression of the specific retention volume (Vg,T), a theoretically coherent and relatively simple mathematical evidence of the elution behaviour of the homologous members has been deduced. It gives exponential retention time dependence on carbon number for isothermal, and nearly equidistant (i.e., approximately linear retention-time dependence on carbon number) elution for linear temperature programmed gas chromatographic runs. The final equations are in close correlation with the experimental results. Special emphasis is placed on the fact that a good approximation—not strict physical laws—have been found. 相似文献
109.
《BJU international》2006,98(Z2):9-12
The tamsulosin oral‐controlled absorption system (OCAS®) is a new tablet formulation of the α1‐adrenoceptor (α1‐AR) antagonist tamsulosin, which is used for treating lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). The tablet uses the OCAS technology, which was specifically designed to give a more continuous 24‐h release of tamsulosin, resulting in a more consistent and continuous 24‐h plasma concentration, a lower maximum plasma concentration (Cmax) and an independence of pharmacokinetics (PKs) on food intake. It was expected that the improved PK profile would translate into a better control of day‐ and night‐time symptoms of BPH and a lower risk of adverse events. Phase I PK studies showed that tamsulosin OCAS indeed has a flattened PK profile with a lower Cmax and a more stable and consistent 24‐h concentration of tamsulosin, independent of food intake, compared to conventional tamsulosin. A study combining γ‐scintigraphy and PK analysis of blood samples confirmed that the improved PK profile of tamsulosin OCAS is attributed to the tablet being consistently and continuously released throughout the entire gastrointestinal tract, including the colon. 相似文献
110.
Elderly men with clinical and laboratory evidence of androgen deficiency are eligible for testosterone treatment.
With proper monitoring this is acceptably safe.
In the first year of testosterone treatment there should be a digital rectal examination of the prostate and measurement of prostate specific antigen every three months, thereafter yearly.
The rate of increase of prostate specific antigen (PSA) levels is more significant than its absolute values.
Levels of haemoglobin and the haematocrit should be monitored. 相似文献